CODIFI2: Randomised controlled trial to compare clinical and cost‐effectiveness of swabs versus tissue sampling to inform management of infected diabetic foot ulcers
Authors:
- E. Andrea NelsonENE. Andrea Nelson
- Sarah T. BrownSBSarah T. Brown
- Colin C. EverettCEColin C. Everett
- Angela OatesAOAngela Oates
- Michael BackhouseMBMichael Backhouse
- Howard CollierHCHoward Collier
- Rachael GilbertsRGRachael Gilberts
- Michelle M. ListerMLMichelle M. Lister
- Jane E. NixonJNJane E. Nixon
- David RussellDRDavid Russell
Open Access
- 6 March 2025
- journal article
- Published by Wiley in Diabetic Medicine
- Vol. 42 (5) , e70009
Abstract
BAims/Hypothesis: CODIFI2 compared wound swabbing and tissue sampling in people with infected diabetic foot ulcers (DFU) to determine the effects on clinical outcomes.Methods: Multicentre, Phase III, prospective, non‐blind, 2‐arm parallel group, randomised controlled trial comparing time to ulcer healing (primary outcome), proportions healed, antimicrobial regimen, ulcer area reduction, hospitalisation duration, and time to death for swab compared to tissue sampling. Allocation was via a central and independent randomisation system, with minimisation by DFU site, number, type, size, location, and duration.Follow‐up was 52–104 weeks, with healing confirmed by a blinded assessor. Samplesize target was 730 participants for 90% power to detect a 12.5% difference in healing at 52 weeks.Results: Between May 2019 and May 2022, 149 participants were recruited (75 Swab, 74 Tissue) from 21 UK sites. The 52‐week cumulative incidence of confirmed healing as the first event was 45.3% (33.5%–56.4%) and 44.6% (33.0–55.6%) for swab vs. tissue. The hazard ratio (HR) for healing for tissue vs. swab was 1.01 (95% CI 0.65–1.55). The median (IQR) days in hospital was 17 (12–39) for swab and 16 (10–32) for tissue. Seventeen swab and 7 tissue participants died during follow‐up, and 18.7% and 24.3% of participants in the swab and tissue groups, respectively, had an amputation.Conclusions/Interpretation: This trial was underpowered to determine whether swab or tissue sampling impacted the rate of healing or time to healing. Clinical prescribing and patient outcomes differed slightly between groups; hence, the clinical benefit of tissue sampling is not established.Keywords
Funding Information
- National Institute for Health and Care Research
This publication has 17 references indexed in Scilit:
- Diabetic Foot Ulcers and Their RecurrenceNew England Journal of Medicine, 2017
- Antimicrobial stewardship in wound care: a Position Paper from the British Society for Antimicrobial Chemotherapy and European Wound Management AssociationJournal of Antimicrobial Chemotherapy, 2016
- Deep tissue biopsy vs. superficial swab culture, including microbial loading determination, in the microbiological assessment of Skin and Soft Tissue Infections (SSTIs)Journal of Chemotherapy, 2016
- IWGDF guidance on the diagnosis and management of foot infections in persons with diabetesDiabetes/Metabolism Research and Reviews, 2016
- Diabetic foot infections: Current treatment and delaying the ‘post‐antibiotic era’Diabetes/Metabolism Research and Reviews, 2016
- A Comparison of Tissue versus Swab Culturing of Infected Diabetic Foot WoundsInternational Journal of Endocrinology, 2016
- 2012 Infectious Diseases Society of America Clinical Practice Guideline for the Diagnosis and Treatment of Diabetic Foot InfectionsaClinical Infectious Diseases, 2012
- Competing risks regression for clustered dataBiostatistics, 2011
- A Proportional Hazards Model for the Subdistribution of a Competing RiskJournal of the American Statistical Association, 1999
- THE QUANTITATIVE SWAB CULTURE AND SMEAR1976